Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-17 9:11 pm Unchanged | 2025-03-12 | 13D | Dogwood Therapeutics, Inc. DWTX | Sealbond Limited | 211,383 15.900% | 0 (Unchanged) | Filing History |
| 2025-03-17 5:53 pm Sale | 2025-03-14 | 13G | Dogwood Therapeutics, Inc. DWTX | Orca Capital AG | 69,821 3.700% | -45,969 (-39.70%) | Filing History |
| 2025-03-17 5:49 pm Purchase | 2025-03-12 | 13G | Dogwood Therapeutics, Inc. DWTX | Orca Capital AG | 115,790 6.100% | 115,790 (New Position) | Filing History |
| 2024-10-15 4:19 pm Purchase | 2024-10-07 | 13D | Dogwood Therapeutics, Inc. DWTX | Sealbond Limited | 211,383 15.900% | 211,383 (New Position) | Filing History |
| 2024-02-13 6:01 pm Sale | 2024-02-13 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 882,400 4.600% | -433,649 (-32.95%) | Filing History |
| 2023-11-14 1:40 pm Sale | 2023-11-14 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 1,316,049 6.840% | -11,002 (-0.83%) | Filing History |
| 2023-06-13 4:41 pm Purchase | 2023-06-13 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 1,327,051 7.300% | 27,071 (+2.08%) | Filing History |
| 2023-05-15 1:37 pm Purchase | 2023-05-15 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 1,299,980 7.100% | 36,782 (+2.91%) | Filing History |
| 2023-03-31 2:33 pm Purchase | 2023-03-30 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 1,263,198 6.900% | 113,449 (+9.87%) | Filing History |
| 2023-02-14 08:08 am Sale | 2022-12-31 | 13G | Virios Therapeutics, Inc. VIRI | MASTERS CAPITAL MANAGEMENT LLC | 0 0.000% | -700,000 (Position Closed) | Filing History |
| 2023-02-13 5:26 pm Sale | 2022-12-31 | 13G | Virios Therapeutics, Inc. VIRI | Ionic Ventures, LLC | 697,292 3.800% | -1,132,708 (-61.90%) | Filing History |
| 2023-02-13 4:16 pm Purchase | 2023-02-13 | 13G | Virios Therapeutics, Inc. VIRI | Burch Richard Alan | 448,056 2.400% | 2,625 (+0.59%) | Filing History |
| 2023-02-13 4:13 pm Purchase | 2023-02-13 | 13G | Virios Therapeutics, Inc. VIRI | Pridgen William | 753,819 4.100% | 25,508 (+3.50%) | Filing History |
| 2023-02-13 4:09 pm Purchase | 2023-02-13 | 13G | Virios Therapeutics, Inc. VIRI | Duncan Gregory Scott | 501,715 2.700% | 40,833 (+8.86%) | Filing History |
| 2023-02-13 2:48 pm Purchase | 2023-02-13 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 1,149,749 6.300% | 76,797 (+7.16%) | Filing History |
| 2022-12-21 1:43 pm Purchase | 2022-12-14 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 1,072,952 5.900% | 1,072,952 (New Position) | Filing History |
| 2022-09-21 4:53 pm Purchase | 2022-09-20 | 13G | Virios Therapeutics, Inc. VIRI | Ionic Ventures, LLC | 1,830,000 9.980% | 1,830,000 (New Position) | Filing History |
| 2022-02-14 09:46 am Purchase | 2021-12-31 | 13G | Virios Therapeutics, Inc. VIRI | Pridgen William | 728,311 8.700% | 18,519 (+2.61%) | Filing History |
| 2022-02-14 09:46 am Purchase | 2021-12-31 | 13G | Virios Therapeutics, Inc. VIRI | Duncan Gregory Scott | 460,882 5.300% | 21,057 (+4.79%) | Filing History |
| 2022-02-14 09:45 am Purchase | 2021-12-31 | 13G | Virios Therapeutics, Inc. VIRI | Burch Richard Alan | 445,431 5.200% | 5,250 (+1.19%) | Filing History |